Cases of complete BCP-ALL substitution by AML are also foreseeable, as they have occurred in patients with KMT2A rearrangements, but their timely identification required careful investigation of all main BM compartments during MFC-MRD analysis, as recommended previously [9]. This evidence concerns the gene OPN1SW and acute myeloid leukemia.